NTV Asset Management LLC grew its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 28.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,756 shares of the company's stock after purchasing an additional 8,824 shares during the quarter. NTV Asset Management LLC's holdings in Procter & Gamble were worth $5,776,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of PG. BlackRock Inc. purchased a new position in Procter & Gamble in the second quarter valued at $27,862,105,000. State Street Corp raised its stake in Procter & Gamble by 1.0% in the second quarter. State Street Corp now owns 102,216,308 shares of the company's stock valued at $14,988,999,000 after buying an additional 965,461 shares in the last quarter. Bank of America Corp DE purchased a new stake in Procter & Gamble during the 2nd quarter worth about $3,850,628,000. Bank of New York Mellon Corp purchased a new stake in Procter & Gamble during the 2nd quarter worth about $2,281,505,000. Finally, Dimensional Fund Advisors LP lifted its holdings in Procter & Gamble by 2.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company's stock worth $1,704,182,000 after buying an additional 300,280 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Procter & Gamble Price Performance
Shares of NYSE:PG opened at $161.21 on Friday. The company's fifty day moving average price is $148.41 and its 200 day moving average price is $147.09. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $167.25. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.47. The firm has a market capitalization of $374.43 billion, a P/E ratio of 24.28, a P/E/G ratio of 4.00 and a beta of 0.39.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, beating analysts' consensus estimates of $1.89 by $0.11. Procter & Gamble had a net margin of 18.23% and a return on equity of 30.91%. The firm had revenue of $23.28 billion during the quarter, compared to analysts' expectations of $22.80 billion. During the same period in the previous year, the company earned $1.99 earnings per share. Procter & Gamble's quarterly revenue was up 4.0% compared to the same quarter last year. As a group, sell-side analysts predict that Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be given a dividend of $1.0885 per share. The ex-dividend date is Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.7%. Procter & Gamble's payout ratio is 65.51%.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on PG. BNP Paribas Exane increased their price objective on Procter & Gamble from $177.00 to $189.00 and gave the company an "outperform" rating in a report on Friday. Barclays raised their target price on Procter & Gamble from $146.00 to $152.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 21st. Argus cut Procter & Gamble from a "buy" rating to a "hold" rating in a research note on Friday, August 7th. HSBC reaffirmed a "hold" rating and issued a $149.00 price target (down from $182.00) on shares of Procter & Gamble in a report on Thursday, July 30th. Finally, Sanford C. Bernstein reiterated a "market perform" rating and issued a $149.00 price target on shares of Procter & Gamble in a research note on Monday, August 24th. Fifteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat.com, Procter & Gamble presently has an average rating of "Moderate Buy" and an average target price of $168.90.
View Our Latest Research Report on Procter & Gamble
Procter & Gamble News Roundup
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Multiple analysts raised targets and maintained bullish ratings. UBS lifted its target to $190 and retained a Buy rating, while Citigroup raised its target to $187, BNP Paribas Exane to $189, and JPMorgan to $180. Freedom Broker also upgraded PG from Hold to Buy with a $176 target. These revisions suggest analysts believe the earnings improvement and resilient demand can support further gains.
- Positive Sentiment: Fiscal Q1 results exceeded expectations. Adjusted EPS was $2.00 versus the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, topping estimates of approximately $22.80 billion. Organic sales also grew 4%, with volume contributing 2.4 percentage points. Procter & Gamble earnings beat as sales rise 4%
- Positive Sentiment: Demand and operating trends remain encouraging. Stronger volumes, favorable product mix, productivity savings, and resilient laundry and home-product sales supported the quarter. Investors also continue to value PG’s defensive business mix and 70-year record of dividend increases. P&G dividend history
- Neutral Sentiment: Fiscal 2027 guidance was mixed. The company raised its all-in sales-growth outlook, partly reflecting the Thorne acquisition, but projected revenue of $86.0 billion to $87.7 billion remains below the roughly $88.8 billion consensus. EPS guidance of $6.89 to $7.11 brackets expectations of $6.98.
- Negative Sentiment: Commodity and energy inflation remain the main risks. Higher oil, raw-material, transportation, and energy costs are expected to create an estimated $1.4 billion headwind and pressure margins. TD Cowen raised its target to $166 but kept a Hold rating, warning that cost inflation could limit the recovery. P&G commodity cost outlook
Insiders Place Their Bets
In related news, CEO Paul Gama sold 2,225 shares of the firm's stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $323,381.50. Following the transaction, the chief executive officer owned 51,124 shares in the company, valued at $7,430,362.16. This trade represents a 4.17% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Susan Whaley sold 2,369 shares of Procter & Gamble stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $344,310.46. Following the transaction, the insider directly owned 30,730 shares in the company, valued at approximately $4,466,298.20. This trade represents a 7.16% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 15,135 shares of company stock worth $2,189,970. Corporate insiders own 0.23% of the company's stock.
About Procter & Gamble
(
Free Report)
Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
Featured Stories
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.